Company intelligence / Profile preview

Trevarx Biomedical

Philadelphia, Pennsylvania, United Statestrevarx.com ↗
Ownership
Private
Development stage
Other
01

Overview

Trevarx Biomedical is advancing two main programs. [18F]FluorThanatrace ([18F]FTT), a PET imaging biomarker for PARP1 expression, is in Phase 2 multicenter trials in breast cancer with over 296 patients imaged and no adverse events reported. The second program, [211At]PTT, an alpha-emitting therapeutic targeting PARP1, has shown strong preclinical efficacy in neuroblastoma models and is preparing for Phase 1 trials in ovarian cancer. The company’s dual diagnostic/therapeutic approach enables precision oncology by matching patients to appropriate therapies based on real-time tumor biology.

Therapeutic areas
Oncology
Modalities
Small moleculeDiagnostic radiopharmaceuticalsTherapeutic radiopharmaceuticals
Industry
Biotech
02

Drug pipeline

2 assets

astatine-211-parthanatine

Preclinical

1 more asset in the full pipeline.

03

Partnerships

MD Anderson Cancer CenterUniversity of PennsylvaniaWashington University at St. LouisUniversity of Washington

Beyond the preview

Go deeper on Trevarx Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trevarx Biomedical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call